Tianjin Chase Sun Pharmaceutical Co Ltd (300026) — Net Asset Quality Index
Tianjin Chase Sun Pharmaceutical Co Ltd (300026) has a Net Asset Quality Index of 84.1% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥10.37 Billion minus total liabilities of CN¥1.65 Billion yields net assets of CN¥8.72 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read 300026 total debt and obligations for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Tianjin Chase Sun Pharmaceutical Co Ltd Net Asset Quality Index Over Time (2006–2024)
This chart shows how Tianjin Chase Sun Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 19 annual periods from 2006 to 2024. As of March 2026, the index stands at 84.1%, representing net assets of CN¥8.72 Billion against total assets of CN¥10.37 Billion CNY. For live market cap and overall valuation, see how much is Tianjin Chase Sun Pharmaceutical Co Ltd worth.
Annual Net Asset Quality Index for Tianjin Chase Sun Pharmaceutical Co Ltd (2006–2024)
The table below presents the year-by-year Net Asset Quality Index for Tianjin Chase Sun Pharmaceutical Co Ltd from 2006 to 2024, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check 300026 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 78.8% | CN¥8.80 Billion | CN¥11.17 Billion | CN¥2.37 Billion | ▲ +3.9 pp |
| 2023 | 74.9% | CN¥8.87 Billion | CN¥11.84 Billion | CN¥2.97 Billion | ▲ +7.9 pp |
| 2022 | 67.0% | CN¥8.46 Billion | CN¥12.63 Billion | CN¥4.17 Billion | ▼ -1.5 pp |
| 2021 | 68.5% | CN¥7.95 Billion | CN¥11.61 Billion | CN¥3.65 Billion | ▼ -4.1 pp |
| 2020 | 72.6% | CN¥7.39 Billion | CN¥10.18 Billion | CN¥2.79 Billion | ▼ -11.3 pp |
| 2019 | 83.9% | CN¥7.07 Billion | CN¥8.43 Billion | CN¥1.36 Billion | ▼ -4.0 pp |
| 2018 | 87.9% | CN¥6.58 Billion | CN¥7.48 Billion | CN¥907.61 Million | ▲ +0.3 pp |
| 2017 | 87.6% | CN¥6.51 Billion | CN¥7.43 Billion | CN¥919.62 Million | ▲ +4.7 pp |
| 2016 | 82.9% | CN¥6.04 Billion | CN¥7.28 Billion | CN¥1.24 Billion | ▲ +1.2 pp |
| 2015 | 81.7% | CN¥5.29 Billion | CN¥6.47 Billion | CN¥1.18 Billion | ▲ +4.2 pp |
| 2014 | 77.5% | CN¥2.36 Billion | CN¥3.04 Billion | CN¥684.85 Million | ▲ +0.8 pp |
| 2013 | 76.7% | CN¥1.70 Billion | CN¥2.22 Billion | CN¥516.40 Million | ▼ -0.2 pp |
| 2012 | 77.0% | CN¥1.39 Billion | CN¥1.80 Billion | CN¥415.19 Million | ▲ +2.4 pp |
| 2011 | 74.6% | CN¥1.05 Billion | CN¥1.41 Billion | CN¥357.47 Million | ▼ -11.2 pp |
| 2010 | 85.8% | CN¥1.10 Billion | CN¥1.28 Billion | CN¥182.14 Million | ▼ -1.5 pp |
| 2009 | 87.3% | CN¥926.88 Million | CN¥1.06 Billion | CN¥134.90 Million | ▲ +29.5 pp |
| 2008 | 57.8% | CN¥125.51 Million | CN¥217.14 Million | CN¥91.63 Million | ▲ +22.8 pp |
| 2007 | 35.0% | CN¥61.24 Million | CN¥175.03 Million | CN¥113.79 Million | ▲ +14.8 pp |
| 2006 | 20.1% | CN¥21.28 Million | CN¥105.62 Million | CN¥84.34 Million | — |